Dark Horse Consulting Group Acquires Converge Consulting
September 18, 2025
Dark Horse Consulting Group (DHCG), a global strategic and operational consulting firm focused on cell and gene therapy and biotherapeutics, has acquired Converge Consulting, LLC, a Cambridge-based life sciences consulting firm. The acquisition expands DHCG's capabilities in supply chain, manufacturing, commercial launch readiness, enterprise IT solutions, CMC, and Quality to provide broader end-to-end support across the product development lifecycle.
- Buyers
- Dark Horse Consulting Group
- Targets
- Converge Consulting, LLC
- Industry
- Consulting
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Dark Horse Consulting Group Acquires Bruder Consulting & Venture Group
January 9, 2026
Consulting
Dark Horse Consulting Group (DHCG) has acquired Bruder Consulting & Venture Group (BCVG), integrating BCVG as a Regenerative Medicine department within DHC to expand the group's capabilities in regenerative medicine, tissue repair, and biomaterials. The deal brings BCVG's strategic advisory expertise in discovery, development, clinical design, and regulatory affairs into DHCG's global consulting platform.
-
Dark Horse Consulting Group Acquires BioTechLogic, Inc.
October 3, 2024
Consulting
Dark Horse Consulting Group (DHC), a WestView Capital Partners–backed consulting platform, has acquired BioTechLogic, Inc., a CMC, manufacturing, quality and regulatory consulting firm serving biopharma and advanced therapies. The deal combines BioTechLogic's hands-on technical operations expertise with DHC's strategic CGT capabilities to expand service offerings across biologics, vaccines and cell & gene therapy clients.
-
Danforth Advisors Acquires Elite BioPharma Consulting
September 6, 2023
Healthcare Services
Danforth Advisors has acquired Elite BioPharma Consulting to expand its Development Strategy & Operations (DS&O) practice, adding clinical development operations, project and trial management, clinical monitoring, program management, regulatory affairs, and medical writing capabilities. The founders of Elite will continue to lead the team as Danforth integrates Elite's expertise into its variable resource model for life science companies.
-
WestView Capital Partners Makes Growth Investment in Dark Horse Consulting Group
October 4, 2022
Healthcare Services
Boston-based growth equity firm WestView Capital Partners has completed a growth investment in Dark Horse Consulting Group (DHC), a Walnut Creek, California–based consultancy specializing in cell and gene therapy (CGT) CMC and regulatory strategy. The investment will support DHC's continued growth and expansion of its service offerings and global team, and WestView principals will join DHC's board.
-
Troika Media Group Acquires Converge Direct LLC for $125 Million
February 24, 2022
Marketing & Advertising
Troika Media Group, Inc. (Nasdaq: TRKA) has signed a definitive agreement to acquire Converge Direct, LLC, a performance marketing and customer acquisition business, for $125 million. The acquisition adds Converge's HELIX business-intelligence platform and ~85 employees to Troika, substantially expanding Troika's digital media, performance marketing and analytics capabilities and increasing recurring revenue.
-
Arcline Investment Management Invests in Dark Horse Consulting Group
July 30, 2019
Healthcare Services
Arcline Investment Management made a growth investment in Dark Horse Consulting Group to support the company's expansion of cGMP products and services for the cell and gene therapy industry. The capital commitment is intended to accelerate Dark Horse's ability to meet rising client demand across manufacturing, regulatory, and CMC consulting.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.